Crystal forms of N- [2-(diethylamino)ethyl] - 5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol- - 3-ylidene)methyl]-2,4-dimethyl-1H-pyrro le-3carboxamide and methods for their preparation

Details for Australian Patent Application No. 2009221458 (hide)

Owner Ratiopharm GmbH

Inventors Boese, Roland; Mohamad, Nesrin; Latz, Rudiger; Striegel, Hans-Gunter

Agent Davies Collison Cave

Pub. Number AU-A-2009221458

PCT Pub. Number WO2009/109388

Priority 08004143.7 06.03.08 EP

Filing date 5 March 2009

Wipo publication date 11 September 2009

International Classifications

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/109388 Priority application(s): WO2009/109388

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221462-Metering device

2009221456-Connecting piece for a clamping connector